Encapsulating your ideas


SyVento BioTech is a biotechnology company offering comprehensive services in the development of lipid-based nanocarriers and LNP technology. We specialize in the development of lipid-based formulations for pharmaceutical products, including RNA-based drug products.

Our platform solutions enable the efficient design and implementation of projects to encapsulate and deliver therapeutic molecules, such as small molecules, RNA, DNA, and proteins.


Genetic platform

SyVento BioTech’s R&D Team offers technical and scientific support throughout the entire process, including advice on troubleshooting and optimization of RNA synthesis conditions. Our RNA synthesis proficiency guarantees successful results in downstream applications.

By incorporating these important features, our genetic platform for RNA synthesis
provides:

  • high-quality
  • reliablility
  • cost-effectivness

Delivery platform

Our Team’s qualifications and experience provide a wealth of expertise in the development of lipid-based delivery systems.

SyVento BioTech’s LNP delivery systems:

  • help overcome the challenges of delivering fragile and easily degraded RNA molecules
  • improve the efficacy of mRNA based drugs
  • are designed and optimized to achieve specific drug delivery goals
  • their modularity allows for precise control over the size, surface charge, and composition

Manufacturing platform

Our capabilities offer the possibility of scaling the production of formulations based on lipid nanocarriers by transferring solutions developed in the laboratory on a semi-technical and technical scale.

Thanks to the extensive equipment base, we are able to perform:

  • up-scaling starting from very small batches (from lab scale to pilot & demo scale) and up to 50L batches
  • vials filling: 2000-3000 vials per hour (FnF) of continuous filling

Drug development expertise

Our analytical services have been tailored to assist our Partners in their development projects, while also being available to support any standalone analytical initiative.

100% of SyVento BioTech Research and Development Team have PhD in  Life science – mainly biotechnology and chemistry.

Leveraging Insights from the 3rd mRNA Analytical Development Summit for Enhanced mRNA Therapeutics

January 30, 2024

Leveraging Insights from the 3rd mRNA Analytical Development Summit for Enhanced mRNA Therapeutics

SyVento BioTech is committed to staying at the forefront of mRNA therapeutics development. Our participation in the upcoming 3rd mRNA Analytical Development Summit is a testament to this commitment. Representing us at this pivotal event are our CTO, Dominik Lipka PhD Eng., and Marcelina Radko-Zwierzyńska, Manager of Research and Quality Control Laboratory. The summit promises […]

SyVento BioTech Partners with Jagiellonian University’s FBBB for a Biotechnological Leap Forward

October 18, 2023

SyVento BioTech Partners with Jagiellonian University’s FBBB for a Biotechnological Leap Forward

Exciting developments are on the horizon! SyVento BioTech is proud to announce a partnership with the Faculty of Biochemistry, Biophysics, and Biotechnology (FBBB) at Jagiellonian University. Jagiellonian University’s FBBB is renowned for its contributions to modern biology. Combined with SyVento BioTech’s innovative technologies, this collaboration aims to push the boundaries of biotechnological research. Beyond joint […]

SyVento BioTech Welcomes Kajetan Bartosik as New CEO

October 9, 2023

SyVento BioTech Welcomes Kajetan Bartosik as New CEO

SyVento BioTech is delighted to announce the appointment of Kajetan Bartosik as its new Chief Executive Officer. With over 16 years in leadership at the MS Galleon Group, Kajetan Bartosik is renowned for building and leading top-performing teams. His time underscores his unwavering commitment and expertise. He’s successfully set up and transformed businesses, whether launching […]

SyVento BioTech Participates in the Polish-British Future of Healthcare Event

September 27, 2023

SyVento BioTech Participates in the Polish-British Future of Healthcare Event

LONDON, September 26, 2023 – The Polish-British Future of Healthcare Event, focusing on advancements in MedTech, BioTech, and scientific research, will soon take place at the Royal Society of Medicine. SyVento BioTech will be represented by Tomasz Piec, Chairman of the Supervisory Board, and Dominik Lipka, our CTO. International Cooperation in BioTech: A Business Imperative […]

SyVento BioTech Partners with LifeScience Kraków Cluster: A Global Vision with Local Roots

September 11, 2023

SyVento BioTech Partners with LifeScience Kraków Cluster: A Global Vision with Local Roots

SyVento BioTech Partners with LifeScience Kraków Cluster: A Global Vision with Local Roots In a strategic move that aims to consolidate our position as a leader in biotechnology and life sciences, SyVento BioTech is proud to announce our official partnership with the LifeScience Kraków Cluster. Established in 2006, the LifeScience Kraków Cluster has consistently served […]

SyVento BioTech at the Forefront of RNA Therapeutics and Vaccines Conference

August 31, 2023

SyVento BioTech at the Forefront of RNA Therapeutics and Vaccines Conference

In an era where breakthroughs in RNA therapeutics are revolutionizing medicine, SyVento BioTech’s expertise in Lipid Nanoparticle (LNP) formulations stands out as a beacon. LNPs are pivotal for the efficient delivery of mRNA-based drug products, and our team has been pioneering advancements in this domain. It’s with this background that we are thrilled to announce […]

SyVento BioTech at PHASE 2023 Conference

August 24, 2023

SyVento BioTech at PHASE 2023 Conference

SyVento BioTech at PHASE 2023 Conference The PHASE 2023 Conference stood as one of the most crucial discussions in the Polish biotech arena. It highlighted the present situation, outlined objectives, and shed light on both the opportunities available and the challenges to address. Events like these are instrumental in propelling the biotech industry in Poland […]

Reflecting on Our Participation in the 13th International Scientific Conference on Alkaptonuria

August 1, 2023

Reflecting on Our Participation in the 13th International Scientific Conference on Alkaptonuria

  We are proud to look back on our participation in the recently concluded 13th International Scientific Conference on Alkaptonuria (AKU) that took place in Bratislava, Slovakia. This significant event brought together AKU researchers, academics, and clinicians from all over the world. Our team was represented by our R&D Director, Dominik Lipka, PhD Eng., and […]

Aktualizacja Siedziby SyVento Sp. z o.o. / Change of Registered Office of SyVento sp. z o.o.

June 6, 2023

Aktualizacja Siedziby SyVento Sp. z o.o. / Change of Registered Office of SyVento sp. z o.o.

Jest nam niezmiernie miło poinformować, że SyVento Sp. z o.o. z dniem 5 czerwca 2023 roku oficjalnie przenosi swoją siedzibę. Nowy adres wpisany do Krajowego Rejestru Sądowego przez Sąd Rejestrowy to: ul. Za Górą 19, 32 – 050 Skawina. Ta zmiana jest bezpośrednim wynikiem naszej inwestycji w Centrum Badań i Rozwoju Biotechnologicznego w Skawinie oraz […]

Contact Us


Let's collaborate and create quality liposome encapsulated drugs together.